• Surinporn Likhitsathian, Offer E Edelstein, Manit Srisurapanont, Yuval Zolotov, Nuntaporn Karawekpanyawong, Alexander Reznik, and Richard Isralowitz.
• Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
• Complement Ther Med. 2021 Jun 1; 59: 102720.

ObjectivesTo examine attitudes and beliefs about medical cannabis (MC), and specifically about its application for pain management, across medical students in Israel and Thailand.DesignCross-sectional survey which measured attitudes and beliefs about MC. Participants were additionally asked to rate the perceived efficacy of MC for different medical conditions that are related to pain (arthritis, chronic pain, fibromyalgia and multiple sclerosis). Pearson's Chi-squared test was used to compare between students from the participating universities.Results430 medical students participated, 37.9 % (n = 163) from Israel and 62.1 % (n = 267) from Thailand. Personal cannabis use was reported by 55.6 % of the Israeli and only by 6.9 % of the Thai students (p < .001). Israeli secular students, compared to those from Thailand, were more likely to recommend MC for patient treatment, less concerned about serious physical and mental health risks, and more inclined to support legalization of recreational cannabis. Israeli students reported more permissive attitudes toward MC, but reported feeling less prepared to answer patient/client questions about MC than their Thai counterparts.ConclusionsThe findings of this study accentuate the need for curriculum designed around MC use to promote students' preparedness to serve patients in pain or with other medical conditions that may benefit from MC use.Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

7 keywords...

hide…